Related Experiment Videos
Buccal nitroglycerin in congestive cardiac failure: a multicentre study.
The Journal of International Medical Research
|January 1, 1986
Summary
Buccal nitroglycerin improved congestive cardiac failure symptoms in elderly patients. This additional therapy demonstrated sustained benefits in symptom reduction and functional capacity over a 6-month study period.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Elderly patients often present with congestive cardiac failure (CCF).
- Standard CCF therapies (diuretics, inotropic agents) may not fully resolve symptoms.
- Exploring adjunctive treatments is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of buccal nitroglycerin as an add-on therapy for elderly patients with CCF.
- To assess symptom improvement and functional classification changes.
- To determine the duration of therapeutic benefit.
Main Methods:
- A study involving 192 elderly patients diagnosed with CCF.
- Patients received standard CCF therapy plus buccal nitroglycerin.
- Assessment of symptoms and functional classification over a 6-month period.
Main Results:
- Symptom improvements were observed within 14 days of initiating buccal nitroglycerin.
- Enhanced functional classification was noted in the patient cohort.
- These positive effects were maintained throughout the entire 6-month study duration.
Conclusions:
- Buccal nitroglycerin is an effective adjunctive therapy for elderly patients with CCF.
- The addition of buccal nitroglycerin leads to rapid and sustained symptom relief.
- This treatment offers a valuable option for managing refractory CCF symptoms in the elderly.